您的位置: 首页 > 农业专利 > 详情页

Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
专利权人:
Amgen Inc.
发明人:
Yie, Junming,Shi, Donghui,Lloyd, David J.,Wang, Jinghong,Sivits Jr., Glenn N.,Veniant-Ellison, Murielle M.,Komorowski, Renee,Agrawal, Neeraj,Bates, Darren L.,Clavette, Brandon C. P.,Foltz, Ian N.,Ho,
申请号:
AU2016378739
公开号:
AU2016378739A1
申请日:
2016.12.21
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
Methods of treating metabolic diseases and disorders using an antigen binding protein specific for the GIPR polypeptide are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy. In certain embodiments the antigen binding protein is administered in combination with a GLP-1 receptor agonist.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充